02/03/2026
🧊 𝗗𝗲𝗺𝘆𝘀𝘁𝗶𝗳𝘆𝗶𝗻𝗴 𝗙𝗿𝗼𝘇𝗲𝗻 𝗦𝗵𝗼𝘂𝗹𝗱𝗲𝗿: 𝗔 𝗗𝗲𝗲𝗽 𝗗𝗶𝘃𝗲 𝗶𝗻𝘁𝗼 𝗗𝗶𝗮𝗴𝗻𝗼𝘀𝗶𝘀 𝗮𝗻𝗱 𝗠𝗮𝗻𝗮𝗴𝗲𝗺𝗲𝗻𝘁
◻️ Have you ever encountered a patient (or suffered yourself) from a shoulder that simply refuses to move? Adhesive capsulitis, commonly known as "frozen shoulder," is a painful and frustrating condition characterized by joint capsule fibrosis, leading to restricted active and passive motion. It affects roughly 2% to 5% of the general population, primarily adults between 40 and 65 years old, and is more common in women.
◻️ A comprehensive 2026 review in The American Journal of Medicine breaks down the latest understanding of this condition, challenging old assumptions and outlining evidence-based treatments. Here are the key takeaways:
❗ 𝗜𝘁 𝗜𝘀 𝗡𝗼𝘁 𝗔𝗹𝘄𝗮𝘆𝘀 "𝗦𝗲𝗹𝗳-𝗟𝗶𝗺𝗶𝘁𝗶𝗻𝗴"
◻️ Traditionally, frozen shoulder was thought to be a strictly self-limiting condition that would eventually resolve on its own. However, growing evidence and longitudinal studies now show that a substantial proportion of patients experience persistent pain, stiffness, and functional limitations for years after the onset of symptoms. This underscores the need for proactive, individualized management rather than a uniform "wait-and-see" approach.
⚠️ 𝗪𝗮𝘁𝗰𝗵 𝗢𝘂𝘁 𝗳𝗼𝗿 𝗦𝘆𝘀𝘁𝗲𝗺𝗶𝗰 𝗥𝗶𝘀𝗸 𝗙𝗮𝗰𝘁𝗼𝗿𝘀
◻️ While primary adhesive capsulitis develops spontaneously, secondary forms are strongly linked to systemic diseases. Diabetes mellitus is the strongest risk factor, with a prevalence of 10% to 30% among diabetic patients. These patients face a 3- to 5-fold increased risk of developing the condition, often suffering from greater severity, higher rates of bilateral involvement, and a poorer response to standard treatments. Thyroid disease, particularly hypothyroidism, also increases the risk by 1.5 to 2 times.
⏳ 𝗧𝗵𝗲 𝗧𝗵𝗿𝗲𝗲 𝗦𝘁𝗮𝗴𝗲𝘀 𝗼𝗳 𝗙𝗿𝗼𝘇𝗲𝗻 𝗦𝗵𝗼𝘂𝗹𝗱𝗲𝗿
◻️ The disease classically progresses through three overlapping phases:
◻️ Freezing (2–9 months): Characterized by progressive, deep-seated pain and marked pain at end-range movements.
◻️ Frozen (4–12 months): Stiffness predominates, with a persistent restriction of motion but a reduction in pain intensity.
◻️ Thawing (5–24 months): Gradual improvement in range of motion and diminishing pain.
◻️ However, clinicians shouldn't rely rigidly on these stages, as progression isn't always linear, duration varies widely among individuals, and the stages do not perfectly predict treatment responses.
🩺 𝗗𝗶𝗮𝗴𝗻𝗼𝘀𝗶𝘀 𝗶𝘀 𝗖𝗹𝗶𝗻𝗶𝗰𝗮𝗹 (𝗦𝗸𝗶𝗽 𝘁𝗵𝗲 𝗥𝗼𝘂𝘁𝗶𝗻𝗲 𝗠𝗥𝗜)
◻️ The hallmark of frozen shoulder is the global painful restriction of passive glenohumeral range of motion, particularly in external rotation. Patients typically present with an insidious onset of a deep-seated ache that worsens at night and disrupts sleep.
◻️ Crucially, advanced imaging like MRIs or ultrasounds are not routinely required to establish the diagnosis. While standard X-rays should be used to rule out osteoarthritis or fractures, advanced imaging should be reserved for cases with atypical presentations, to exclude other pathologies (like rotator cuff tears), or when initial treatments fail.
𝗔 𝗦𝘁𝗲𝗽𝘄𝗶𝘀𝗲 𝗔𝗽𝗽𝗿𝗼𝗮𝗰𝗵 𝘁𝗼 𝗧𝗿𝗲𝗮𝘁𝗺𝗲𝗻𝘁
◻️ Management is predominantly non-operative. Here is what the evidence supports:
◻️ 📚 Patient Education: Setting realistic expectations about the prolonged timeline and warning patients about the risk to the contralateral shoulder is a critical first step.
◻️ 💊 Corticosteroid Injections: Intra-articular steroid injections are highly effective early on, particularly during the "freezing" phase. When combined with structured physical therapy, they provide superior short-term pain relief and functional improvement compared to exercise alone. Lower doses (10 mg) may actually provide superior results compared to higher doses.
◻️ 🏃 Physical Therapy (PT): A structured PT program focusing on joint mobilization and graduated home exercises plays a central role. Interestingly, a recent trial found that "watchful waiting" can sometimes provide similar functional outcomes to PT but at a lower cost, emphasizing that intervention intensity should be tailored to the individual.
◻️ 💧 Hydrodilatation: Injecting a large volume of fluid (often saline with corticosteroid) to stretch and rupture the contracted joint capsule is a highly effective intervention for pain relief and functional improvement.
◻️ ⚡ Alternatives for Diabetics: Because corticosteroids can disrupt glycemic control, Extracorporeal Shockwave Therapy (ESWT) has emerged as a promising, high-ranking alternative to improve function safely for diabetic patients.
🔧 𝗪𝗵𝗲𝗻 𝗶𝘀 𝗦𝘂𝗿𝗴𝗲𝗿𝘆 𝗡𝗲𝗰𝗲𝘀𝘀𝗮𝗿𝘆?
◻️ Surgical interventions, such as Manipulation Under Anesthesia (MUA) and arthroscopic capsular release, are reserved for refractory cases—typically after 6 to 12 months of failed conservative management.
◻️ The landmark UK FROST trial revealed that both MUA and capsular release offer substantial improvements at 12 months, with no clinically important differences between them. However, MUA proved to be the more cost-effective option, while capsular release carries higher costs but allows direct visualization of the joint.
✅ 𝗧𝗵𝗲 𝗕𝗼𝘁𝘁𝗼𝗺 𝗟𝗶𝗻𝗲
◻️ Frozen shoulder is a complex, often debilitating condition that requires an individualized treatment strategy based on disease stage, symptom severity, and underlying comorbidities. By combining early education, targeted injections, and tailored therapy, clinicians can significantly improve the quality of life for patients battling this frustrating joint restriction.